Parsons Capital Management Inc Moderna, Inc. Transaction History

Parsons Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$101.21 - $166.61 $178,129 - $293,233	1,760 New	1,760 $209,000
Q2 2022 Jul 29, 2022	SELL	$117.13 - $176.59 $7,027 - $10,595	-60 Reduced 3.3%	1,760 $251,000
Q1 2022 May 02, 2022	SELL	$126.46 - $235.05 $58,171 - $108,123	-460 Reduced 20.18%	1,820 $314,000
Q4 2021 Feb 07, 2022	SELL	$225.82 - $368.51 $175,010 - $285,595	-775 Reduced 25.37%	2,280 $579,000
Q3 2021 Nov 09, 2021	BUY	$221.9 - $484.47 $333,959 - $729,127	1,505 Added 97.1%	3,055 $1.18 Million
Q2 2021 Aug 03, 2021	SELL	$129.91 - $234.98 $25,982 - $46,996	-200 Reduced 11.43%	1,550 $364,000
Q1 2021 Apr 28, 2021	BUY	$109.18 - $185.98 $191,065 - $325,465	1,750 New	1,750 $229,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Parsons Capital Management Inc with notifications on news.